Stocks and Investing Stocks and Investing
Tue, May 28, 2024

Kristen Kluska Reiterated (TSHA) at Buy and Held Target at $7 on, May 28th, 2024


Published on 2024-10-28 11:38:05 - WOPRAI, Kristen Kluska
  Print publication without navigation


Kristen Kluska of Cantor Fitzgerald, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $7 on, May 28th, 2024.

Kristen has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Kristen's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Kristen


  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $7 on, Wednesday, May 15th, 2024
  • Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Tuesday, April 9th, 2024
  • Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Increased Target to $7 on, Thursday, March 21st, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024
Contributing Sources